Ben Comer

Most Recent Articles by Ben Comer

Forest Labs to acquire Clinical Data, add reps for launch

Forest Labs will acquire Clinical Data for $1.2 billion, and expand its primary care sales forces in preparation for the launch of Viibryd (vilazodone HCI), executives said in a conference call.

Savient focusing on reimbursement

Savient Pharmaceuticals launched Krystexxa, an orphan drug for chronic gout, and deployed a mix of sales reps, education specialists and business managers to help expedite reimbursement from payers.

Ex-GSK marketer unveils migraine consumer site

Health Union, an online health information and social media company, announced the launch of its first website --Migraine.com--intended to foster "interactions about health conditions between and among patients, caregivers, professionals and providers."

Roche maintained DTC spending on Boniva, while competitors cut back

Roche maintained DTC spending on Boniva, while competitors cut back

Sally Field's winsome smile may have helped to curb declining sales of Roche's Boniva in 2010, but it didn't carry the drug past Warner Chilcott's Actonel, despite a substantially higher DTC spend.

Savient focuses on reimbursement for Krystexxa launch

Savient focuses on reimbursement for Krystexxa launch

Savient Pharmaceuticals launched Krystexxa (pegloticase), an orphan drug for chronic gout, on Monday, and deployed a mix of sales reps, education specialists and business managers to help expedite reimbursement from payers, executives said on a conference call.

More Articles by Ben Comer


Email Newsletters


Specialty medicines continue to be a hot category, one in which spending has surged behind products that treat medicine's most complex diseases. This eBook lays out the needs and hurdles along the specialty drug pathway, explaining how stakeholders are working to get meds into patients' hands and ease their experience. Click here to download.